Stempeutics to launch its stem cell based new drug in India by 2012
Stempeutics Research, a biotechnology company developing stem cell based medicinal products, is all set to introduce its investigational new drug (IND) in India by 2012. The drug is being developed in India is for acute myocardial infarction and critical limb ischemia.
[Read the full article here]Related News:
Stempeutics demonstrates capability to produce stem cell based drugs for 10,000+ patients
Stempeutics To Introduce Stem Cell Drug In 2013
Stem Cell Developer Mesoblast Seeks Bone Marrow Therapy by 2012